SG Americas Securities LLC Increases Investment in Perrigo Company plc

☀️Trending News

SG Americas Securities LLC has recently increased its stake in Perrigo Company ($NYSE:PRGO) plc, as reported by Defense World. Perrigo Company plc is a leading global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and prescription (Rx) pharmaceuticals, as well as consumer products, nutritional products and active pharmaceutical ingredients (API). The company operates primarily in the United States, Ireland, Israel, Mexico, Europe, India, Australia and New Zealand. The company also owns and operates an extensive network of retail pharmacies and has developed an extensive portfolio of branded consumer products.

Perrigo has a long-standing commitment to corporate responsibility and is dedicated to the highest standards of safety and quality. The stock is widely seen as a good investment due to its strong balance sheet, diverse product offerings and experienced management team. With the recent increase in investment, this could be a great opportunity for investors to capitalize on the potential of Perrigo Company plc.

Market Price

On Monday, the stock opened at $36.6 and closed at the same price, a 0.2% increase from its previous closing price. This investment marks an increased confidence in the company and its abilities to perform well in the future. It is yet to be seen how this investment will help PERRIGO COMPANY move forward and what impact it will have on its shareholders. For now, investors must wait for further developments as the company moves forward. Live Quote…

About the Company

Income Snapshot

Below shows the total revenue, net income and net margin for Perrigo Company. More…

Cash Flow Snapshot

Below shows the cash from operations, investing and financing for Perrigo Company. More…

Balance Sheet Snapshot

Below shows the total assets, liabilities and book value per share for Perrigo Company. More…

Key Ratios Snapshot

Some of the financial key ratios for Perrigo Company are shown below. More…

Analysis

As GoodWhale, I have undertaken the task of analyzing PERRIGO COMPANY‘s fundamentals. From our Star Chart analysis, PERRIGO COMPANY has a high health score of 7/10 considering its cashflows and debt. This indicates that the company is strong enough to ride out any crisis without the risk of bankruptcy. In terms of financials, PERRIGO COMPANY is strong in dividend, medium in profitability and weak in asset and growth. Therefore, we classify it as a ‘cow’, which is a type of company that has the track record of paying out consistent and sustainable dividends. Given that PERRIGO COMPANY has a high health score and is able to pay out consistent dividends, it is likely to be attractive to investors who are looking for investments with low risks and steady returns. Therefore, investors who are looking for low-risk investments with steady returns might be interested in such company. More…

Peers

Yuhan Corp, JW Pharmaceutical and Lavipharm SA are all competitors of Perrigo Co PLC.

– Yuhan Corp ($KOSE:000105)

Yuhan Corp is a South Korean conglomerate that operates in the pharmaceutical and chemical industries. It has a market cap of 3.83T as of 2022 and a Return on Equity of 4.29%. The company was founded in 1926 and is headquartered in Seoul. It is one of the largest companies in South Korea and is a major player in the global pharmaceutical market.

– JW Pharmaceutical ($KOSE:001060)

As of 2022, JW Pharmaceutical has a market cap of 396.36B and a Return on Equity of 13.04%. The company is a global pharmaceutical company that develops, manufactures, and markets prescription and over-the-counter medicines.

Summary

SG Americas Securities LLC recently increased their stake in Perrigo Company plc, a leading global healthcare supplier of over-the-counter consumer goods and generic pharmaceuticals. From a financial perspective, Perrigo appears to be a sound investment.